4th Quarter - Report

PHARMATHENE, INC for PHARMATHENE, INC

Period 4th Quarter 2011 Filed Jan 18, 2012 Signed by Mark E Cooke, Sr. Director Government Affairs

Official filing
Firm
PHARMATHENE, INC
Client
PHARMATHENE, INC
Income
—
Expenses
$211,875
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) in the House (H.R. 2405) and the Seante (S. 1855). Education and awareness of the need for medical countermeasures (MCM's) for chemcial and biological threats. Need for second generation recombinant anthrax vaccine (rPA).

LobbyistCovered position, as disclosed
FRANCESCA COOK Sr. VP Policy and Government Affairs
MARK EDWARD COOKE Sr. Director Government Affairs

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2405 (112th), S. 1855 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.